Charles Schwab Investment Management »

Nurix Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.4M 642k 14.70
2023-12-31 $6.4M 622k 10.32
2023-09-30 $4.5M 569k 7.86
2023-06-30 $3.8M 384k 9.99
2023-03-31 $3.4M 385k 8.88
2022-12-31 $4.2M 383k 10.98
2022-09-30 $4.9M 375k 13.03
2022-06-30 $3.7M 291k 12.67
2022-03-31 $3.8M 270k 14.01
2021-12-31 $7.6M 264k 28.95
2021-09-30 $7.8M 260k 29.96
2021-06-30 $3.4M 130k 26.53
2021-03-31 $3.5M 113k 31.10
2020-12-31 $2.5M 77k 32.89
2020-09-30 $2.5M 72k 34.91